浙江康恩贝制药股份有限公司关于高级管理人员离任的公告

Group 1 - The company announced the resignation of Vice President Shen Qi due to work adjustments, effective upon receipt of the resignation letter by the board [2][3] - After resigning, Shen Qi will no longer hold the position of Investment Director but will continue as Chairman of the board for a subsidiary [2] - Shen Qi's departure is not expected to impact the company's normal operations and management, and he did not hold any shares in the company at the time of his resignation [3] Group 2 - The company has entered a restricted exercise period for its stock option incentive plan from October 24 to October 29, 2025, during which all incentive recipients will be restricted from exercising their options [4][5] - The company will apply to the relevant authorities for the necessary procedures regarding the restriction on exercising options [5]